Featured
Last news
Cordless Pet Feeder: ELECOM Introduces Rechargeable Ultra-Quiet Pet Fountain
New battery-powered model offers flexibility, quiet operation, and clean filtered water for pets anywhere in the home.
New to The Street's Featured Client - Roadzen's DrivebuddyAI(TM) Platform Recognized as Key Innovator in InCabin Market Map Report
NEW YORK CITY, NEW YORK / ACCESS Newswire / June 10, 2025 / Roadzen Inc. (NASDAQ:RDZN), a global leader at the intersection of artificial intelligence, insurance, and mobility, today announced that its flagship AI-powered platform, DrivebuddyAI™, has been prominently featured in the latest InCabin Market Map Report. The report, released in advance of InCabin USA 2025 in Detroit-the premier event for driver and occupant monitoring technologies-spotlights DrivebuddyAI™ as a key innovator shaping the future of intelligent in-cabin safety and automation.
New to The Street TV Spotlights Synergy CHC (NASDAQ:SNYR) as Former Coca-Cola Executive Joins to Drive FOCUSfactor(R) Energy Drink's Global Expansion
NEW YORK, NY / ACCESS Newswire / June 10, 2025 / New to The Street, the nationally televised business show airing on Bloomberg and FOX Business, proudly features Synergy CHC Corp. (NASDAQ:SNYR) as a spotlight company, highlighting the brand's strategic expansion in the global functional beverage market. The feature follows Synergy's high-profile appointment of Damian Marano, a former Coca-Cola executive, as the company's new Vice President of Beverage.
Four California Health Systems Accelerate AI-Driven Mental Health Care Accessibility for Millions of Patients with Precise Behavioral
LOS ANGELES, CA / ACCESS Newswire / June 10, 2025 / Precise Behavioral announced today a series of transformative agreements with four California healthcare provider organizations for AI-driven mental health solutions, collectively covering 200 hospitals, 30,000 licensed beds, 100,000 providers, and 24 million patients. The contracts leverage a hybrid virtual and in-person solution model to dramatically scale care accessibility for patients who require mental health services. These agreements validate Precise as a trusted national leader in meeting the growing market demand for behavioral health solutions.
Miriam Laundry Publishing Celebrates Five Years of Children's Book Publishing Excellence
With 185 published titles and nearly 4,000 aspiring authors supported, MLP is transforming the children’s publishing landscape, one story at a time.
Summer 2025 Fashion Trends Embrace Natural Elements and Versatile Styling
Purvi Kanji, vice president of COTERIE, unveils the pivotal trends set to dominate the women's contemporary apparel market this summer, drawing insights from comprehensive content report from Informa's fashion portfolio.
Hypha Labs Files New Patent Application for Its Suite of Artificial Intelligence (AI) Techniques for Its Mushroom Accelerator
LAS VEGAS, NV / ACCESS Newswire / June 10, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), an Artificial Intelligence (AI) powered pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, is pleased to announce the filing of a new patent application with the United States Patent and Trade Office (USPTO) for its current suite of Artificial Intelligence (AI) powered techniques to create functional mushroom ingredients in its Mushroom Accelerator.
New to The Street's Esteemed Client Arrive AI Secures Another Key Patent for its Smart Mailbox-Anchored Autonomous Last-Mile Delivery Solutions Platform
NEW YORK CITY, NY / ACCESS Newswire / June 10, 2025 / Arrive AI (NASDAQ:ARAI), a pioneering autonomous delivery network anchored by its patented Arrive Points™, announced today the issuance of a new U.S. patent for its AI-powered, smart mailbox platform. This patent expands the system's capabilities by enabling temperature-controlled heating and cooling - critical for sectors requiring precision handling such as pharmaceuticals and biotechnology.
Newsmax2 FAST Channel Sees 25% Growth in May
BOCA RATON, FL / ACCESS Newswire / June 10, 2025 / Newsmax Inc. (NYSE:NMAX) ("Newsmax" or the "Company") today reported May ratings for the Company's free streaming channel Newsmax2, with an increase of 25% in total viewership year-over-year.
The Arthritis Foundation Drives Awareness and Support During Juvenile Arthritis Awareness Month
From the Juvenile Arthritis Family Summit to research and advocacy, national efforts shine a light on the resilience of kids and families living with juvenile arthritis.
Heritage Distilling Holding Company, Inc. CEO & Co-Founder Justin Stiefel to Present at the Investor Summit Virtual on June 10, 2025
GIG HARBOR, WA / ACCESS Newswire / June 10, 2025 / Heritage Distilling Holding Company, Inc. (NASDAQ:CASK) announced that Justin Stiefel, CEO and Co-Founder, will be presenting at the Investor Summit Virtual taking place on June 10.
Aspire Biopharma Holdings, Inc., Announces Michael C. Howe - With Decades of Experience at Leading and Building Brands in the Healthcare and Consumer Space - To Be Its New Chief Executive Officer
Michael Howe - who currently serves as an Independent Board Member - to assume CEO role on June 10, 2025Michael's career spans nationally recognized brands such as MinuteClinic, Procter & Gamble, PepsiCo, CEO of Arby's, and as an early-stage investor/board member in healthcare and software businesses
Wellgistics Health Joins OptiSource to Expand Access and Drive Savings for Independent Pharmacies
TAMPA, FL / ACCESS Newswire / June 10, 2025 / Wellgistics Health (NASDAQ:WGRX) ("Wellgistics Health"), a next-generation drug distribution, digital script routing, and hub fulfillment platform, is proud to announce its official membership in OptiSource, LLC, a group purchasing organization that provides innovative business solutions, group purchasing programs, and other efficiency-enhancing and cost-saving services to its members. This strategic move significantly enhances Wellgistics Health's purchasing power, product access, and support for community-based pharmacy partners.
DEA DIVERSION Scandal Exposed - Marijuana Drug Development Obstruction
DEA Back to Training School, DEA Bureaucrat Blocks Science While Ignoring their Own TRAINING Manual. DEA Assistant Administrators and attorney needs a summer assignment, and MMJ BioPharma Cultivation has a suggestion: go back and read your own policy statement and training manual.
ANGLE plc Announces Novel Discoveries Into the Biology of Cancer
PARSORTIX SYSTEM enableS novel DISCOVERIES into the biology of cancerAcademic and translational research is the driving force behind the pipeline of next generation cancer therapeutics
Jurors making 'good progress' towards Weinstein retrial verdict
Jurors reported getting closer to a verdict Monday in the sex crimes retrial of disgraced Hollywood mogul Harvey Weinstein, despite tensions raising the risk of a deadlocked jury and a mistrial.
Tensions flare among jurors in Weinstein sex crimes retrial
Fresh strains emerged Monday among jurors in the sex crimes retrial of disgraced Hollywood mogul Harvey Weinstein, raising the risk of a deadlocked jury and a mistrial.
Malaysia bus crash kills at least 15, mostly students
A bus carrying university students back to their campus smashed into a minivan in northern Malaysia on Monday, killing at least 15 people, police and rescue services said.
Israel diverts Gaza-bound aid boat carrying Greta Thunberg
Israel intercepted a Gaza-bound aid boat on Monday morning, preventing the activists onboard, including Swedish campaigner Greta Thunberg, from reaching the blockaded Palestinian territory.
Israel says Gaza-bound activist boat carrying Greta Thunberg redirected
Israel said it diverted a Gaza-bound boat on Monday after the activists onboard, including Swedish campaigner Greta Thunberg, said they were intercepted as they sought to provide relief to the blockaded Palestinian territory.
Alexandre de Moraes: Brazilian judge in showdown with far-right
With his steely gaze and bald pate, Supreme Court judge Alexandre de Moraes has emerged as one of the most powerful and polarizing people in Brazil.
Aytu BioPharma Announces Closing of Upsized At the Market Public Offering of Common Stock with Full Exercise of Overallotment and Conference Call to Discuss First-in-Class Antidepressant EXXUA(TM) Opportunity and Commercialization Plan
Gross proceeds from offering total $16.6 million.Financing led by long-term, healthcare-focused institutional investors, including Aytu's largest shareholders Nantahala Capital Management and Stonepine Capital Management, with participation from Aytu management and new institutional shareholders.Aytu enters the over $22 billion United States prescription major depressive disorder ("MDD") market with the first-in-class oral selective serotonin 5HT1a receptor agonist for adults with MDD.EXXUA has demonstrated significant improvement in depression symptoms in clinical trials involving more than 5,000 patients and, notably, the incidence of sexual side effects experienced with EXXUA was comparable to placebo.EXXUA is expected to serve as a major growth catalyst as Aytu continues to build value for shareholders; the Company anticipates launching EXXUA in the fourth calendar quarter of 2025 as a centerpiece of its commercial efforts.Conference call to discuss the EXXUA opportunity and commercialization plan scheduled for Wednesday, June 11, 2025, at 4:30 p.m. Eastern time.
REMINDER: Jaguar Health to Conduct Fireside Chat 9AM ET June 10 as Part of Lytham Partners’ Spring 2025 Spotlight Series
Click here to registerDiscussion will focus on company's May 2025 meeting with the FDA to review the statistically significant responder analysis results for the subgroup of breast cancer patients in company's recently conducted Phase 3 OnTarget trialThe currently estimated US metastatic breast cancer population potentially qualifies as an orphan population, in alignment with company's core focus on orphan diseasesCompany plans to promptly pursue authorization to initiate expanded access program for patients with breast cancer who may not be eligible for a potential pivotal treatment trial with crofelemer in patients with metastatic breast cancer
Commercialville.TV Launches Zip-Code Targeted Video Search Platform with Times Square Billboard Debut and Continuing National Broadcast TV Rollout via New to The Street
NEW YORK CITY, NY / ACCESS Newswire / June 9, 2025 / Commercialville.TV, the internet's first and only zip-code-targeted, video-based search engine, has officially launched with a bold, integrated media campaign including Times Square billboard exposure, a feature release on the New to The Street TV YouTube Channel, and a continuing national broadcast television rollout across Fox Business and Bloomberg Television.
Celebrate Dad with Up to 50% Off Tech Essentials During ELECOM's Father's Day Sale
Save Up to 25% on Outdoor Gear from NESTOUT for the Adventurous Dad
Colorado Independent Pharmacies Applaud Signing of HB25-1222, Ensuring Fair Reimbursement for Rural and Community Pharmacies
Governor Polis Signs HB25-1222 Into Law, Advancing Fair Reimbursement and Strengthening Independent Pharmacy Care Across Colorado
New to The Street's Documentary Specials Break Records: IMG Academy Surpasses 126,000 Views in Just 12 Days
PetVivo and Acurx Pharmaceuticals Exceed 200,000 Views as investor Demand for Long-Form Corporate Storytelling Surges
Electromed, Inc. to Present at the Investor Summit Virtual on June 10, 2025
NEW PRAGUE, MN / ACCESS Newswire / June 9, 2025 / Electromed, Inc. announced that Jim Cunniff, President and Chief Executive Officer, will be presenting at the Investor Summit Virtual taking place on June 10.About Electromed, Inc. Electromed (NYSE American: ELMD) is a profitable and growing medical device company that develops, manufactures, markets and sells innovative High Frequency Chest Wall Oscillation (HFCWO) airway clearance products, primarily for use in the home setting. Our flagship product, the SmartVest® Airway Clearance System, is a differentiated device designed for patient comfort and ease of use. We believe the domestic market for HFCWO devices is largely untapped, with fewer than 15% of the approximately 824,000 patients diagnosed with bronchiectasis in the US currently using this non-invasive therapy.Event: Q2 Investor SummitPresentation Time: June 10, 11:30 AM ETLocation: WEBCAST LINKConference Overview and StructureThe Investor Summit is an exclusive event for investors who specialize in small and microcap stocks. It is an opportunity to be introduced to and speak with management at some of the most attractive small companies, learn from various subject matter experts, and see what your peers are doing in this market.This quarter's event is focused on MicroCap companies who are undervalued, have a catalyst, and are undervalued.Registration for InvestorsTo request free registration, please go to our website (https://investorsummitgroup.com/), and click the "Registration" button.Sponsors:
Graber Partners with GreenSky(R) to Offer More Buying Power for Dealers
MIDDLETON, WI / ACCESS Newswire / June 9, 2025 / Graber, a leading brand of premium custom window treatments, announced a strategic partnership with GreenSky to offer Graber dealers the opportunity to participate in the GreenSky® Program, a leader in consumer financing solutions. This collaboration is designed to provide Graber dealers with enhanced financing options, enabling them to boost their sales potential and offer more payment plan options to consumers.
Clene Inc. Chief Executive Officer Rob Etherington to Present at the Investor Summit Virtual on June 10, 2025
SALT LAKE CITY, UT / ACCESS Newswire / June 9, 2025 / Clene Inc. announced that Rob Etherington, Chief Executive Officer and President, will be presenting at the Investor Summit Virtual taking place on June 10.About Clene Inc.Clene Inc., (Nasdaq: CLNN) (along with its subsidiaries, "Clene") and its wholly owned subsidiary Clene Nanomedicine Inc., is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson's disease, and multiple sclerosis. CNM-Au8® is an investigational first-in-class therapy that improves central nervous system cells' survival and function via a mechanism that targets mitochondrial function and the NAD pathway while reducing oxidative stress. CNM-Au8® is a federally registered trademark of Clene Nanomedicine, Inc. The company is based in Salt Lake City, Utah, with R&D and manufacturing operations in Maryland. For more information, please visit www.clene.com or follow us onX (formerly Twitter) and LinkedIn.Event: Q2 Investor SummitPresentation Time:1:00 PM ETLocation: WEBCAST LINKConference Overview and StructureThe Investor Summit is an exclusive event for investors who specialize in small and microcap stocks. It is an opportunity to be introduced to and speak with management at some of the most attractive small companies, learn from various subject matter experts, and see what your peers are doing in this market.This quarter's event is focused on MicroCap companies who are undervalued, have a catalyst, and are undervalued.
Jaguar Health Provides Update on Meeting with FDA Discussing Statistically Significant Results of Responder Analysis of Breast Cancer Patients in Phase 3 OnTarget Trial and Potential Approval Pathway for Crofelemer
Productive and collaborative discussion on proposed pathway by the company to bring crofelemer to approval for cancer therapy-related diarrhea (CTD) in patients with metastatic breast cancer receiving selected targeted therapiesThe currently estimated US metastatic breast cancer population would qualify as an orphan population, which aligns with company's core focus on orphan diseasesCompany plans to promptly pursue authorization to initiate expanded access program for patients with breast cancer who may not be eligible for a potential pivotal treatment trial with crofelemer in patients with metastatic breast cancer
Nanox Imaging to Present at the Investor Summit Virtual on June 10, 2025
PETACH TIKVA, ISRAEL / ACCESS Newswire / June 9, 2025 / Nanox Imaging announced that Ran Daniel, Chief Financial Officer, will be presenting at the Investor Summit Virtual taking place on June 10.About Nanox ImagingNanox (NASDAQ:NNOX) is focused on driving the world's transition to preventive health care by bringing a full solution of affordable medical imaging technologies based on advanced AI and proprietary digital X-ray source.